Chemoinformaics analysis of gamma-L-Glutamyl-beta-aminoisobutyric acid
Molecular Weight | 232.236 | nRot | 7 |
Heavy Atom Molecular Weight | 216.108 | nRig | 3 |
Exact Molecular Weight | 232.106 | nRing | 0 |
Solubility: LogS | -1.108 | nHRing | 0 |
Solubility: LogP | -3.822 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 31.9087 |
nHD | 4 | BPOL | 18.6553 |
QED | 0.446 |
Synth | 2.856 |
Natural Product Likeliness | 0.562 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.061 |
HIA | 0.054 |
CACO-2 | -6.199 |
MDCK | 0.00434583 |
BBB | 0.616 |
PPB | 0.0709 |
VDSS | 0.321 |
FU | 0.8274 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.016 |
CYP2c19-inh | 0.043 |
CYP2c19-sub | 0.038 |
CYP2c9-inh | 0.155 |
CYP2c9-sub | 0.314 |
CYP2d6-inh | 0.036 |
CYP2d6-sub | 0.136 |
CYP3a4-inh | 0.013 |
CYP3a4-sub | 0.004 |
CL | 6.845 |
T12 | 0.705 |
hERG | 0.012 |
Ames | 0.018 |
ROA | 0.007 |
SkinSen | 0.111 |
Carcinogencity | 0.011 |
EI | 0.071 |
Respiratory | 0.04 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.879233 |